6.
Osterman M, Hamilton B, Martin J, Driscoll A, Valenzuela C
. Births: Final Data for 2020. Natl Vital Stat Rep. 2022; 70(17):1-50.
View
7.
Lo Y, Chan K, Sun H, Chen E, Jiang P, Lun F
. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010; 2(61):61ra91.
DOI: 10.1126/scitranslmed.3001720.
View
8.
Kuhlmann-Capek M, Chiossi G, Singh P, Monsivais L, Lozovyy V, Gallagher L
. Effects of medication intake in early pregnancy on the fetal fraction of cell-free DNA testing. Prenat Diagn. 2019; 39(5):361-368.
DOI: 10.1002/pd.5436.
View
9.
Agrawal S, Cerdeira A, Redman C, Vatish M
. Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study. Hypertension. 2017; 71(2):306-316.
DOI: 10.1161/HYPERTENSIONAHA.117.10182.
View
10.
Bolnick J, Kohan-Ghadr H, Fritz R, Bolnick A, Kilburn B, Diamond M
. Altered Biomarkers in Trophoblast Cells Obtained Noninvasively Prior to Clinical Manifestation of Perinatal Disease. Sci Rep. 2016; 6:32382.
PMC: 5034887.
DOI: 10.1038/srep32382.
View
11.
Hou Y, Yang J, Qi Y, Guo F, Peng H, Wang D
. Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening. Hum Genomics. 2019; 13(1):62.
PMC: 6894209.
DOI: 10.1186/s40246-019-0244-0.
View
12.
Merviel P, Challier J, Carbillon L, Foidart J, Uzan S
. The role of integrins in human embryo implantation. Fetal Diagn Ther. 2001; 16(6):364-71.
DOI: 10.1159/000053942.
View
13.
Grati F, Malvestiti F, Ferreira J, Bajaj K, Gaetani E, Agrati C
. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med. 2014; 16(8):620-4.
DOI: 10.1038/gim.2014.3.
View
14.
Bourlard L, Manigart Y, Donner C, Smits G, Desir J, Migeotte I
. Rarity of fetal cells in exocervical samples for noninvasive prenatal diagnosis. J Perinat Med. 2022; 50(4):476-485.
DOI: 10.1515/jpm-2021-0291.
View
15.
Hong K, Jang H, Shim S, Cho H, Cha D
. Advanced Strategy of Trophoblasts Retrieval and Isolation from the Cervix (TRIC): Comparison of Two HLA-G Antibodies for Immunomagnetic Isolation of Trophoblasts. J Pers Med. 2023; 13(1).
PMC: 9865439.
DOI: 10.3390/jpm13010022.
View
16.
Hong K, Kim S, Cha D, Park H
. Defective Uteroplacental Vascular Remodeling in Preeclampsia: Key Molecular Factors Leading to Long Term Cardiovascular Disease. Int J Mol Sci. 2021; 22(20).
PMC: 8539609.
DOI: 10.3390/ijms222011202.
View
17.
Kim K, Craft L
. Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US. BMJ Open. 2022; 12(6):e057658.
PMC: 9204434.
DOI: 10.1136/bmjopen-2021-057658.
View
18.
Bolnick A, Fritz R, Jain C, Kadam L, Bolnick J, Kilburn B
. Trophoblast Retrieval and Isolation From the Cervix for Noninvasive, First Trimester, Fetal Gender Determination in a Carrier of Congenital Adrenal Hyperplasia. Reprod Sci. 2016; 23(6):717-22.
PMC: 5933151.
DOI: 10.1177/1933719116632922.
View
19.
Sun K, Jiang P, Wong A, Cheng Y, Cheng S, Zhang H
. Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing. Proc Natl Acad Sci U S A. 2018; 115(22):E5106-E5114.
PMC: 5984542.
DOI: 10.1073/pnas.1804134115.
View
20.
Adinolfi M, Sherlock J, Ward R, Petrou M, Rodeck C
. Prenatal detection of Hb mutations using transcervical cells. Prenat Diagn. 1997; 17(6):539-43.
DOI: 10.1002/(sici)1097-0223(199706)17:6<539::aid-pd106>3.0.co;2-8.
View